Related Experiment Video

Updated: Jun 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Benefits of statin therapy and compliance in high risk cardiovascular patients

Joel A Lardizabal1, Prakash C Deedwania

  • 1Division of Cardiology, Department of Medicine, University of California in San Francisco (Fresno-MEP), Fresno, CA, USA.

Vascular Health and Risk Management
|October 20, 2010
PubMed

Insights

Statin therapy significantly benefits patients with cardiovascular disease (CVD), including coronary heart disease and stroke. Improving patient adherence to statin treatment is crucial for realizing these life-saving benefits.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) is the leading cause of global mortality.
  • Statin therapy is proven to reduce mortality and morbidity in coronary heart disease (CHD) and stroke.
  • Statins offer benefits in other high-risk conditions like diabetes, chronic kidney disease (CKD), congestive heart failure (CHF), and peripheral vascular disease (PVD).

Purpose of the Study:

  • To review the established benefits of statin therapy in various cardiovascular conditions.
  • To highlight the issue of suboptimal patient compliance with statin treatment.
  • To emphasize the need for interventions that enhance long-term adherence to statin therapy.

Main Methods:

  • Review of existing evidence on statin therapy benefits.
  • Analysis of factors contributing to poor statin adherence.
  • Discussion of clinical guidelines recommending statin use.

Main Results:

  • Statin therapy demonstrates significant mortality and morbidity benefits in primary and secondary prevention of CHD and stroke.
  • Guidelines universally recommend statin use in high-risk CVD patients.
  • Suboptimal patient compliance remains a significant barrier to realizing the full benefits of statin therapy.

Conclusions:

  • Enhancing long-term statin adherence in real-world settings is essential.
  • Addressing patient, physician, and economic factors is key to improving compliance.
  • Interventions promoting adherence are vital to maximize the public health impact of statin therapy.

Keywords:
cardiovascular diseasecoronary heart diseaselong-term treatment compliancestatin therapy

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...